Department of Education, Faculty of Education Sciences; SPORT Research Group (CTS-1024), CERNEP Research Centre, University of Almería, Almería, Spain.
General and Bariatric Surgery Unit, Torrecárdenas University Hospital, Almería, Spain.
Obes Surg. 2021 Oct;31(10):4227-4235. doi: 10.1007/s11695-021-05559-8. Epub 2021 Jul 15.
Previous studies have investigated weight loss caused by exercise following bariatric surgery. However, in most cases, the training program is poorly reported; the exercise type, volume, and intensity are briefly mentioned; and the sample size, selection criteria, and follow-up time vary greatly across studies.
The EFIBAR study aims to investigate over 1 year the effects of a 16-week supervised exercise program, initiated immediately after bariatric surgery, on weight loss (primary outcome), body composition, cardiometabolic risk, physical fitness, and quality of life in patients with severe/extreme obesity.
The EFIBAR study is a parallel-group, superiority, randomized controlled trial (RCT), comprising 80 surgery patients. Half of the participants, randomly selected, perform a 16-week supervised exercise program, including both strength and aerobic training, starting immediately after the surgery (7-14 days). For each participant, all primary and secondary outcomes are measured at three different time points: (i) before the surgery, (ii) after the intervention (≈4 months), and (iii) 1 year after the surgery.
The EFIBAR study will provide new insights into the multidimensional benefits of exercise in adults with severe/extreme obesity following bariatric surgery.
EFIBAR randomized controlled trial was prospectively registered at Clinicaltrials.gov (NCT03497546) on April 13, 2018.
先前的研究已经调查了减重手术后运动引起的体重减轻。然而,在大多数情况下,训练计划的报告较差;仅简要提及运动类型、量和强度;并且研究之间的样本量、选择标准和随访时间差异很大。
EFIBAR 研究旨在调查 16 周的监督运动计划对严重/极度肥胖患者手术后 1 年的体重减轻(主要结果)、身体成分、心脏代谢风险、身体适应性和生活质量的影响。
EFIBAR 研究是一项平行组、优势、随机对照试验(RCT),包括 80 名手术患者。随机选择一半的参与者立即开始进行 16 周的监督运动计划,包括力量和有氧运动。对于每个参与者,所有主要和次要结果都在三个不同时间点进行测量:(i)手术前,(ii)干预后(约 4 个月),(iii)手术后 1 年。
EFIBAR 研究将为肥胖症患者减重手术后运动的多维益处提供新的见解。
EFIBAR 随机对照试验于 2018 年 4 月 13 日在 Clinicaltrials.gov(NCT03497546)前瞻性注册。